Cibus (CBUS) Cash from Investing Activities (2016 - 2025)
Cibus (CBUS) posted Cash from Investing Activities of -$86000.0 for Q4 2025, up 20.37% sequentially from -$108000.0 in Q3 2025, and down 53.57% YoY from -$185230.8 in Q4 2024.
Cibus (CBUS) Cash from Investing Activities (2016 - 2025) Analysis & Trends
Cibus has reported Cash from Investing Activities for 10 years, with the latest figure at -$86000.0 in Q4 2025.
- Quarterly Cash from Investing Activities fell 53.57% year-over-year to -$86000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$578000.0 (up 28.47% YoY) and the FY2025 annual result came in at -$578000.0, up 28.47% from the prior year.
- Cash from Investing Activities rose to -$86000.0 in Q4 2025 per CBUS's latest filing, from -$108000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $58.8 million in Q2 2023 and troughed at -$3.3 million in Q3 2023.
- A 5-year average of $3.3 million and a median of -$121000.0 in 2021 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 8006.05% in 2023, down 3981.82% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$121000.0 in 2021, then jumped by 90.91% to -$11000.0 in 2022, then sank by 3981.82% to -$449000.0 in 2023, then jumped by 87.53% to -$56000.0 in 2024, then plunged by 53.57% to -$86000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$86000.0, -$108000.0, and -$93000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -86,000.00 |
| Dec 31, 2025 | -86,000.00 |
| Sep 30, 2025 | -108,000.00 |
| Sep 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | -291,000.00 |
| Mar 31, 2025 | -291,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | -355,000.00 |
| Sep 30, 2024 | -355,000.00 |
| Jun 30, 2024 | -169,000.00 |
| Jun 30, 2024 | -169,000.00 |
| Mar 31, 2024 | -228,000.00 |
| Mar 31, 2024 | -228,000.00 |
| Dec 31, 2023 | -449,000.00 |
| Dec 31, 2023 | -449,000.00 |
| Sep 30, 2023 | -3.31 Mn |
| Sep 30, 2023 | -3.31 Mn |